LRRK2 mutations in Parkinson's disease patients from Central Europe: A case control study
Language English Country Great Britain, England Media print-electronic
Document type Letter, Research Support, Non-U.S. Gov't
PubMed
33561776
DOI
10.1016/j.parkreldis.2020.12.021
PII: S1353-8020(21)00012-2
Knihovny.cz E-resources
- MeSH
- Humans MeSH
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 genetics MeSH
- Mutation MeSH
- Parkinson Disease genetics MeSH
- Aged MeSH
- Case-Control Studies MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- Hungary MeSH
- Poland MeSH
- Romania MeSH
- Slovakia MeSH
- Names of Substances
- LRRK2 protein, human MeSH Browser
- Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 MeSH
Dept of Medical Biochemistry Jessenius Medical Faculty Commenius University Martin Slovak Republic
Dept of Neurology Commenius University and University Hospital Bratislava Slovak Republic
Dept of Neurology Commenius University and University Hospital Martin Martin Slovak Republic
Dept of Neurology P J Safarik University Kosice Slovak Republic
Dept of Neurology Semmelweis University Budapest Hungary
References provided by Crossref.org
p.L1795F LRRK2 variant is a common cause of Parkinson's disease in Central Europe
Central European Group on Genetics of Movement Disorders
